Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis
Background
Rapid access to pancreatic imaging and regular pancreatic surveillance may help identify stage I pancreatic cancer. We investigated recent trends in the stage of newly diagnosed pancreatic ductal adenocarcinoma (PDACs), age at diagnosis, and survival.
Methods
Trends in age-adjusted incidence of stage IA PDAC between 2004 and 2016 were determined from the National Cancer Institute’s Surveillance, Epidemiology and End Results database. All tests were two-sided.
Results
The incidence of stage IA PDAC cases diagnosed increased statistically significantly from 2004 to 2016 (annual percent change = 14.5, 95% confidence interval [CI] = 11.4 to 17.7; P < .001). During the study period, average age at diagnosis for stage IA and IB casesAQ3 declined by 3.5 years (95% CI = 1.2 to 5.9; P = .004) and 5.5 years (95% CI = 3.4 to 7.6; P < .001), whereas average age increased for higher-stage cases (by 0.6 to 1.4 years). Among stage IA cases, the proportion of blacks was smaller (10.2% vs 12.5%), and the proportion of other non-Caucasians was higher compared with higher-stage cases (11.9% vs 8.4%; P < .001). Stage IA cases were more likely to carry insurance (vs Medicaid or none) than higher-stage cases (cases aged younger than 65 years; odds ratio = 2.45, 95% CI = 1.96 to 3.06; P < .001). The 5-year overall survival for stage IA PDAC improved from 44.7% (95% CI = 31.4 to 63.7) in 2004 to 83.7% (95% CI = 78.6% to 89.2%) in 2012; 10-year survival improved from 36.7% (95% CI = 24.1 to 55.8) in 2004 to 49.0% (95% CI = 37.2% to 64.6%) in 2007.
Conclusions
In recent years, the proportion of patients diagnosed with stage IA PDAC has increased, their average age at diagnosis has decreased, and their overall survival has improved. These trends may be the result of improved early diagnosis and early detection.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Cancers
12 publications, 6.35%
|
|
|
Gastroenterology
6 publications, 3.17%
|
|
|
Journal of Clinical Oncology
5 publications, 2.65%
|
|
|
Cancer Prevention Research
5 publications, 2.65%
|
|
|
Familial Cancer
4 publications, 2.12%
|
|
|
Frontiers in Oncology
3 publications, 1.59%
|
|
|
Scientific Reports
3 publications, 1.59%
|
|
|
Pancreatology
3 publications, 1.59%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.06%
|
|
|
Diagnostics
2 publications, 1.06%
|
|
|
Current Oncology
2 publications, 1.06%
|
|
|
Annals of Surgical Oncology
2 publications, 1.06%
|
|
|
Communications Medicine
2 publications, 1.06%
|
|
|
Clinical Gastroenterology and Hepatology
2 publications, 1.06%
|
|
|
Hematology/Oncology Clinics of North America
2 publications, 1.06%
|
|
|
Zeitschrift fur Gastroenterologie
2 publications, 1.06%
|
|
|
HPB
2 publications, 1.06%
|
|
|
Surgical Oncology Clinics of North America
2 publications, 1.06%
|
|
|
International Journal of Cancer
2 publications, 1.06%
|
|
|
Cancer Medicine
2 publications, 1.06%
|
|
|
Journal of the National Cancer Center
2 publications, 1.06%
|
|
|
JAMA Oncology
2 publications, 1.06%
|
|
|
Cancer Epidemiology Biomarkers and Prevention
2 publications, 1.06%
|
|
|
American Journal of Gastroenterology
2 publications, 1.06%
|
|
|
JCO Precision Oncology
2 publications, 1.06%
|
|
|
Surgery (US)
2 publications, 1.06%
|
|
|
Cureus
2 publications, 1.06%
|
|
|
Journal of Translational Medicine
2 publications, 1.06%
|
|
|
Cancer Control
1 publication, 0.53%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Springer Nature
41 publications, 21.69%
|
|
|
Elsevier
40 publications, 21.16%
|
|
|
MDPI
20 publications, 10.58%
|
|
|
Wiley
14 publications, 7.41%
|
|
|
American Association for Cancer Research (AACR)
9 publications, 4.76%
|
|
|
Georg Thieme Verlag KG
8 publications, 4.23%
|
|
|
American Society of Clinical Oncology (ASCO)
7 publications, 3.7%
|
|
|
Cold Spring Harbor Laboratory
7 publications, 3.7%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 2.65%
|
|
|
Frontiers Media S.A.
5 publications, 2.65%
|
|
|
American Medical Association (AMA)
4 publications, 2.12%
|
|
|
Taylor & Francis
3 publications, 1.59%
|
|
|
AME Publishing Company
3 publications, 1.59%
|
|
|
SAGE
2 publications, 1.06%
|
|
|
JMIR Publications
2 publications, 1.06%
|
|
|
Baishideng Publishing Group
2 publications, 1.06%
|
|
|
BMJ
2 publications, 1.06%
|
|
|
Spandidos Publications
2 publications, 1.06%
|
|
|
eLife Sciences Publications
1 publication, 0.53%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.53%
|
|
|
OAE Publishing Inc.
1 publication, 0.53%
|
|
|
American Roentgen Ray Society
1 publication, 0.53%
|
|
|
S. Karger AG
1 publication, 0.53%
|
|
|
Oxford University Press
1 publication, 0.53%
|
|
|
American Chemical Society (ACS)
1 publication, 0.53%
|
|
|
American Society for Clinical Investigation
1 publication, 0.53%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.53%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.